Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

6.10

+0.01 (0.16%)

Sep 29, 2026, 9:43 AM EDT - Market open

Anbio Biotechnology Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	8.65	8.65	8.19	6.71	23.54	4.43
Revenue Growth	24.95%	5.64%	21.95%	-71.49%	431.67%	-
Gross Profit	7.54	7.54	5.89	3.36	12.56	2.54
Operating Income	5.77	5.77	2	1.96	10.2	2.46
Net Income	6.4	6.4	2.37	2.25	10.01	2.54
Earnings Per Share	0.15	0.15	0.06	0.11	-	-
EPS Growth	144.20%	161.33%	-46.63%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
European Union	5.15	5.15	5.62	4.66	20.3	4.09
Asia Pacific	1.52	1.52	0.51	0.07	3.19	-
North America	0.3	0.3	0.11	0.22	0.05	0.34
South America	0.27	0.27	1.48	1.65	-	-
Other Regions	1.41	1.41	0.47	0.11	-	-
Total	8.65	8.65	8.19	6.71	23.54	4.43

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	11.9	11.9	11.76	9.69	8.67	4.18
Net Cash Growth	-11.38%	1.19%	21.40%	11.75%	107.33%	-
Net Cash Per Share	0.27	0.27	0.28	0.45	-	-
Cash & Investments	11.9	11.9	11.76	9.69	8.67	4.18

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-6.74	-6.74	2.08	0.9	4.45	4.18
Free Cash Flow	-6.74	-6.74	2.08	0.9	4.45	4.18
Free Cash Flow Growth	-	-	131.57%	-79.81%	6.40%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	87.24%	87.24%	71.90%	50.07%	53.36%	57.40%
Operating Margin	66.70%	66.70%	24.38%	29.22%	43.30%	55.46%
Pretax Margin	74.06%	74.06%	28.99%	33.58%	42.52%	57.26%
Profit Margin	74.06%	74.06%	28.99%	33.58%	42.52%	57.26%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	41.53	206.11	-	-	-	-
PS Ratio	30.91	152.64	-	-	-	-